Khendi White Solaru
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Khendi White Solaru has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Heather L. Gornik
Harrington Heart & Vascular Institute, University Hospitals, Cleveland, OH, USA
3 shared publications - Naomi M. Hamburg
Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts (N.M.H.)
2 shared publications - Sadeer Al-Kindi
DeBakey Heart and Vascular Center, Houston Methodist Hospital , Houston, TX
2 shared publications - Akintunde O. Akinkuolie
Division of Preventive Medicine
1 shared publication Betul Hatipoglu
Division of Cardiovascular Medicine University Hospitals Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center Cleveland OH
1 shared publicationChaitra Mohan
Resident, Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA
1 shared publication
Latest Publications
- Open Access
- 18 October 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (20) , e026347
Findings of a Novel Barbershop‐Based Peripheral Artery Disease Screening Program for Black Men
Background: Peripheral artery disease (PAD) increases the risk of cardiovascular events and limb events including amputations. PAD is twice as prevalent in Black compared with non‐Hispanic White individuals, especially among men. Screening for PAD using the ankle–brachial index in community settings, such as the barbershop, could lead to earlier diagnosis and treatment. Methods and Results: A pilot study was conducted at 2 barbershops in Cleveland, OH from June to December 2020 to assess the feasibility of screening for PAD in the barbershop setting and the effect of an educational intervention on PAD awareness. After screening with both automated and Doppler ankle–brachial index, PAD was identified in 5/31 (16.1%) of participants. Baseline systolic blood pressure, low‐density lipoprotein cholesterol, and random blood glucose were higher in participants who screened positive for PAD ( P P =0.004). An association was found between PAD awareness at baseline and highest education level achieved: compared with those with some college/associate's degree or higher, non–high school graduates scored lower on PAD awareness ( P =0.022), as did those who only had a high school diploma or tests of General Educational Development ( P =0.049). Conclusions: In a pilot study, barbershop‐based screening for PAD among Black men revealed a higher than expected PAD prevalence and low PAD awareness. An educational video was effective at increasing PAD awareness. Ankle–brachial index screening and educational outreach in the barbershop may be a feasible and effective tool to diagnose PAD and reduce PAD disparities among Black men at highest risk.
- 18 October 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (20) , e026347
Open AccessFindings of a Novel Barbershop‐Based Peripheral Artery Disease Screening Program for Black Men
Background: Peripheral artery disease (PAD) increases the risk of cardiovascular events and limb events including amputations. PAD is twice as prevalent in Black compared with non‐Hispanic White individuals, especially among men. Screening for PAD using the ankle–brachial index in community settings, such as the barbershop, could lead to earlier diagnosis and treatment. Methods and Results: A pilot study was conducted at 2 barbershops in Cleveland, OH from June to December 2020 to assess the feasibility of screening for PAD in the barbershop setting and the effect of an educational intervention on PAD awareness. After screening with both automated and Doppler ankle–brachial index, PAD was identified in 5/31 (16.1%) of participants. Baseline systolic blood pressure, low‐density lipoprotein cholesterol, and random blood glucose were higher in participants who screened positive for PAD ( P P =0.004). An association was found between PAD awareness at baseline and highest education level achieved: compared with those with some college/associate's degree or higher, non–high school graduates scored lower on PAD awareness ( P =0.022), as did those who only had a high school diploma or tests of General Educational Development ( P =0.049). Conclusions: In a pilot study, barbershop‐based screening for PAD among Black men revealed a higher than expected PAD prevalence and low PAD awareness. An educational video was effective at increasing PAD awareness. Ankle–brachial index screening and educational outreach in the barbershop may be a feasible and effective tool to diagnose PAD and reduce PAD disparities among Black men at highest risk.
- Open Access
- 29 July 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (15) , e024482
Lessons Learned From a Patient‐Centered, Team‐Based Intervention for Patients With Type 2 Diabetes at High Cardiovascular Risk: Year 1 Results From the CINEMA Program
Background: The care for patients with type 2 diabetes necessitates a multidisciplinary team approach to reduce cardiovascular risk, but implementation of effective integrated strategies has been limited. Methods and Results: We conceptualized and initiated a patient‐centered, team‐based intervention called Center for Integrated and Novel Approaches in Vascular‐Metabolic Disease (CINEMA) at University Hospitals Cleveland Medical Center. Patients with type 2 diabetes at high risk for cardiovascular events, including those with established atherosclerotic cardiovascular disease, elevated coronary artery calcium score >100, chronic heart failure with reduced ejection fraction, and/or chronic kidney disease stages 2 to 4 were included. Herein, we present the year 1 results for the program. From May 2020 through August 2021, there were 417 referrals. Among 206 eligible patients, 113 (55%) completed a baseline and ≥1 follow‐up visit through December 2021, with mean (SD) time of 105 (34) days between baseline and first follow‐up visits. Mean age was 59 years, with 49% women and 37% Black patients. Patients had significant reductions from baseline in glycosylated hemoglobin (−10.8%), total cholesterol (−7.9%), low‐density lipoprotein cholesterol (−13.5%), systolic blood pressure (−4.0%), and body mass index (−2.7%) ( P ≤0.001 for all). In addition, among the 129 (63%) eligible patients not on sodium‐glucose cotransporter 2 inhibitor or glucagon‐like peptide‐1 receptor agonist at baseline, 81% were prescribed evidence‐based therapy with sodium‐glucose cotransporter 2 inhibitor (n=66 [51%]) and/or glucagon‐like peptide‐1 receptor agonist (n=67 [52%]) to reduce the risk of cardiovascular disease in the initial 3‐month follow‐up period. Conclusions: A team‐based, patient‐centered approach to high‐risk disease management appears to be a promising paradigm for care delivery associated with greater use of evidence‐based therapies and improved control of multiple cardiovascular risk factors.
- 29 July 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (15) , e024482
Open AccessLessons Learned From a Patient‐Centered, Team‐Based Intervention for Patients With Type 2 Diabetes at High Cardiovascular Risk: Year 1 Results From the CINEMA Program
Background: The care for patients with type 2 diabetes necessitates a multidisciplinary team approach to reduce cardiovascular risk, but implementation of effective integrated strategies has been limited. Methods and Results: We conceptualized and initiated a patient‐centered, team‐based intervention called Center for Integrated and Novel Approaches in Vascular‐Metabolic Disease (CINEMA) at University Hospitals Cleveland Medical Center. Patients with type 2 diabetes at high risk for cardiovascular events, including those with established atherosclerotic cardiovascular disease, elevated coronary artery calcium score >100, chronic heart failure with reduced ejection fraction, and/or chronic kidney disease stages 2 to 4 were included. Herein, we present the year 1 results for the program. From May 2020 through August 2021, there were 417 referrals. Among 206 eligible patients, 113 (55%) completed a baseline and ≥1 follow‐up visit through December 2021, with mean (SD) time of 105 (34) days between baseline and first follow‐up visits. Mean age was 59 years, with 49% women and 37% Black patients. Patients had significant reductions from baseline in glycosylated hemoglobin (−10.8%), total cholesterol (−7.9%), low‐density lipoprotein cholesterol (−13.5%), systolic blood pressure (−4.0%), and body mass index (−2.7%) ( P ≤0.001 for all). In addition, among the 129 (63%) eligible patients not on sodium‐glucose cotransporter 2 inhibitor or glucagon‐like peptide‐1 receptor agonist at baseline, 81% were prescribed evidence‐based therapy with sodium‐glucose cotransporter 2 inhibitor (n=66 [51%]) and/or glucagon‐like peptide‐1 receptor agonist (n=67 [52%]) to reduce the risk of cardiovascular disease in the initial 3‐month follow‐up period. Conclusions: A team‐based, patient‐centered approach to high‐risk disease management appears to be a promising paradigm for care delivery associated with greater use of evidence‐based therapies and improved control of multiple cardiovascular risk factors.
- Open Access
- 19 July 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (15) , e025276
Proportionate and Absolute Vascular Disease Mortality by Race and Sex in the United States From 1999 to 2019
Background: Despite the known significant morbidity and mortality associated with cardiovascular disease and peripheral vascular disease (PVD), contemporary data describing racial demographics in PVD mortality are scarce. Methods and Results: Using the multiple causes of death file from the Centers for Disease Control and Prevention’s Wide‐Ranging Online Data for Epidemiologic Research, we analyzed the trends of age‐adjusted mortality (AAMR) for PVD and its subtypes (aortic aneurysm/dissection, arterial thrombosis, venous thrombosis/disease, pulmonary embolism), by race and sex between 1999 and 2019. Of the 17 826 871 deaths attributed to cardiovascular disease, a total of 888 187 (5.0%) PVD deaths were analyzed during the study period (12.4% Black, 85.6% White). Between 1999 and 2019, AAMR for PVD decreased by 52% (24.8–11.8 per 100 000 people) in the overall population. Despite a decrease in the overall mortality across all race and sex groups, Black men and Black women continued to have higher mortality for PVD (1.5×), aortic dissection (1.8×), arterial thrombosis (1.3×), and venous thrombosis/disease (2.0×) mortality compared with White men and White women in 2019. While there was a 53% decrease in PVD among White individuals (AAMR 24.5–11.5 per 100 000), there was only a 43% decrease (30.0–17.1) in PVD AAMR in Black individuals between 1999 and 2019. The ratio of PVD AAMR increased from 1.2 (1999) to 1.5 (2019) in Black men/White men and from to 1.3 (1999) to 1.5 (2019) in Black women/White women. Similar trends were noted in aortic dissection (Black men/White men, 1.2–1.8; and Black women/White women, 1.5–1.7), arterial thrombosis (Black men/White men, 1.0–1.3; and Black women/White women, 0.9–1.3), and venous thrombosis/disease (Black men/White men, 1.7–1.8; and Black women/White women, 1.7–2.0). Conclusions: In this retrospective review of death certificate data in the United States, we demonstrate continued significant disparities between Black and White populations in PVD mortality and its subtypes. Future studies should investigate etiologies and social determinants of PVD mortality.
- 19 July 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (15) , e025276
Open AccessProportionate and Absolute Vascular Disease Mortality by Race and Sex in the United States From 1999 to 2019
Background: Despite the known significant morbidity and mortality associated with cardiovascular disease and peripheral vascular disease (PVD), contemporary data describing racial demographics in PVD mortality are scarce. Methods and Results: Using the multiple causes of death file from the Centers for Disease Control and Prevention’s Wide‐Ranging Online Data for Epidemiologic Research, we analyzed the trends of age‐adjusted mortality (AAMR) for PVD and its subtypes (aortic aneurysm/dissection, arterial thrombosis, venous thrombosis/disease, pulmonary embolism), by race and sex between 1999 and 2019. Of the 17 826 871 deaths attributed to cardiovascular disease, a total of 888 187 (5.0%) PVD deaths were analyzed during the study period (12.4% Black, 85.6% White). Between 1999 and 2019, AAMR for PVD decreased by 52% (24.8–11.8 per 100 000 people) in the overall population. Despite a decrease in the overall mortality across all race and sex groups, Black men and Black women continued to have higher mortality for PVD (1.5×), aortic dissection (1.8×), arterial thrombosis (1.3×), and venous thrombosis/disease (2.0×) mortality compared with White men and White women in 2019. While there was a 53% decrease in PVD among White individuals (AAMR 24.5–11.5 per 100 000), there was only a 43% decrease (30.0–17.1) in PVD AAMR in Black individuals between 1999 and 2019. The ratio of PVD AAMR increased from 1.2 (1999) to 1.5 (2019) in Black men/White men and from to 1.3 (1999) to 1.5 (2019) in Black women/White women. Similar trends were noted in aortic dissection (Black men/White men, 1.2–1.8; and Black women/White women, 1.5–1.7), arterial thrombosis (Black men/White men, 1.0–1.3; and Black women/White women, 0.9–1.3), and venous thrombosis/disease (Black men/White men, 1.7–1.8; and Black women/White women, 1.7–2.0). Conclusions: In this retrospective review of death certificate data in the United States, we demonstrate continued significant disparities between Black and White populations in PVD mortality and its subtypes. Future studies should investigate etiologies and social determinants of PVD mortality.
- Top Cited Papers
- 11 June 2021
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 128 (12) , 1913-1926
Racial and Ethnic Disparities in Peripheral Artery Disease
Peripheral artery disease is an obstructive, atherosclerotic disease of the lower extremities causing significant morbidity and mortality. Black Americans are disproportionately affected by this disease while they are also less likely to be diagnosed and promptly treated. The consequences of this disparity can be grim as Black Americans bear the burden of lower extremity amputation resulting from severe peripheral artery disease. The risk factors of peripheral artery disease and how they differentially affect certain groups are discussed in addition to a review of pharmacological and nonpharmacological treatment modalities. The purpose of this review is to highlight health care inequities and provide a review and resource of available recommendations for clinical management of all patients with peripheral artery disease.
- 11 June 2021
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 128 (12) , 1913-1926
Top Cited PapersRacial and Ethnic Disparities in Peripheral Artery Disease
Peripheral artery disease is an obstructive, atherosclerotic disease of the lower extremities causing significant morbidity and mortality. Black Americans are disproportionately affected by this disease while they are also less likely to be diagnosed and promptly treated. The consequences of this disparity can be grim as Black Americans bear the burden of lower extremity amputation resulting from severe peripheral artery disease. The risk factors of peripheral artery disease and how they differentially affect certain groups are discussed in addition to a review of pharmacological and nonpharmacological treatment modalities. The purpose of this review is to highlight health care inequities and provide a review and resource of available recommendations for clinical management of all patients with peripheral artery disease.
- 1 February 2021
- Published by Elsevier in Journal of the National Medical Association
- Vol. 113 (1) , 39-42
Pandemic Superimposed on Epidemic: Covid-19 Disparities in Black Americans
- 1 February 2021
- Published by Elsevier in Journal of the National Medical Association
- Vol. 113 (1) , 39-42
Pandemic Superimposed on Epidemic: Covid-19 Disparities in Black Americans
- 31 October 2019
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 13 (11) , 34
Correction to: Peripheral Artery Disease and African Americans: Review of the Literature
- 31 October 2019
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 13 (11) , 34
Correction to: Peripheral Artery Disease and African Americans: Review of the Literature
- 14 October 2019
- Published by SAGE Publications in Vascular Medicine
- Vol. 24 (6) , 566-570
Spontaneous coronary artery dissection (SCAD)
- 14 October 2019
- Published by SAGE Publications in Vascular Medicine
- Vol. 24 (6) , 566-570
Spontaneous coronary artery dissection (SCAD)
- 25 July 2019
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 13 (9) , 27
Peripheral Artery Disease and African Americans: Review of the Literature
- 25 July 2019
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 13 (9) , 27
Peripheral Artery Disease and African Americans: Review of the Literature
- 1 June 2019
- Published by Elsevier in The American Journal of Cardiology
- Vol. 123 (11) , 1812-1815
Prevalence of Coronary Vasospasm Using Coronary Reactivity Testing in Patients With Spontaneous Coronary Artery Dissection
- 1 June 2019
- Published by Elsevier in The American Journal of Cardiology
- Vol. 123 (11) , 1812-1815
Prevalence of Coronary Vasospasm Using Coronary Reactivity Testing in Patients With Spontaneous Coronary Artery Dissection
- 20 May 2019
- Published by SAGE Publications in Vascular Medicine
- Vol. 24 (3) , 287-290
SVM membership spotlight and committee updates
- 20 May 2019
- Published by SAGE Publications in Vascular Medicine
- Vol. 24 (3) , 287-290
SVM membership spotlight and committee updates